Previous studies have demonstrated that administration of CPT-11 strongly reduced the growth of glioma tumors by blocking angiogenesis, reducing the number of tumor vessels and the surface of hypoxic lesions, and significantly decreased expression of VEGF [21]. Here, VEGFA is linked to central nervous system cancer.